Use of riociguat as front-line therapy in a patient with high-risk pulmonary arterial hypertension and right ventricular failure.
30 August 2024 (08:00 - 17:30)
Organised by: 
About the speaker
Unidad Medica de Alta Especialidad Hospital de Cardiologia No. 34 IMSS, Monterrey (Mexico)
3 More presentations in this session
Doctor M. Abbate (Naples, IT)
Doctor E. Palacios (Monterrey, MX)
Doctor H. Nashat (London, GB)
Access the full session
The Event
ESC Congress 2024
30 August - 2 September 2024
